The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
Clinical trial NCT05547529 · RECRUITING
Trial details
- NCT number
- NCT05547529
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2025-09-14
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.